Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis
Emilio Portaccio(University of Florence), Nicola Renato Pizio(Azienda Unità Sanitaria Locale Della Romagna), Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Franco Granella(University of Parma), Paola Valentino(Magna Graecia University), Roberto Balgera, Sergio Parodi(Multiple Sclerosis Foundation), María Trojano(University of Bari Aldo Moro), Carlo Avolio(University of Foggia), Umberto Aguglia(Martin University), Davide Maimone(Ospedale Garibaldi), Lorenzo Razzolini(University of Florence), Marta Rezzonico(Azienda Socio Sanitaria Territoriale Lariana), Renato Mantegazza(Italian Association for Cancer Research), Alessandra Lugaresi(Istituto delle Scienze Neurologiche di Bologna), Ilaria Pesci, Raffaella Clerici(CTO Hospital), Gıancarlo Comı(Casa di Cura Columbus), Maria Pia Amato(University of Florence), Pietro Iaffaldano(University of Bari Aldo Moro), Francesco Logullo(Marche Polytechnic University), Simone Tonietti(Ospedale San Carlo), Marco Salvetti(Istituto Neurologico Mediterraneo), Giovanna De Luca(University of Udine), Rocco Totaro(San Salvatore Hospital), Angelo Bellinvia(University of Florence), Tiziana Tassinari(Multiple Sclerosis Foundation), Paola Banfi, Vincenzo Di Lazzaro(Università Campus Bio-Medico), Luisa Pastò(University of Florence), Matilde Inglese(New York University), Mattia Fonderico(Azienda Usl Toscana Centro), Paola Cavalla, Paola Gazzola(University of Genoa), Simonetta Venturi(Multiple Sclerosis Foundation), Daniele Spitaleri(Azienda Ospedaliera S.Giuseppe Moscati), Simonetta Galgani(IRCCS San Camillo Hospital), Francesco Patti(University of Catania), Paolo Ragonese(University of Palermo), Patrizia Sola(Azienda Ospedaliero-Universitaria di Modena), Carlo Pozzilli(Sapienza University of Rome), Giacomo Lus(University of Campania "Luigi Vanvitelli"), Eleonora Cocco(University of Cagliari), Vincenzo Brescia Morra(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Marika Vianello(Ca' Foncello Hospital), Patrizia Perrone(Multiple Sclerosis Foundation), Salvatore Cottone, Massimo Filippi(Vita-Salute San Raffaele University), Giuseppe Lucisano(Center for Outcomes Research and Clinical Epidemiology), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla)
Cited by 17
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k